SCHEMBL7864324

SCHEMBL7864324

Cc1ccccc1C1C[C@H]1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.58
HTR2A P28223 1/20 0.58
HTR2B P41595 1/20 0.58
KDM1A O60341 12/20 0.57
KDM1B Q8NB78 2/20 0.57
MAOB P27338 8/20 0.48
MAOA P21397 7/20 0.48
CYP2C19 P33261 4/20 0.48
CYP2B6 P20813 3/20 0.48
TAAR1 Q96RJ0 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2A6 P11509 1/20 0.48
SLC6A2 P23975 1/20 0.48
ADRA1A P35348 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094448 1.00 HTR2C (0.58) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL7094447 1.00 HTR2C (0.58) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL25058901 0.83 HTR2C (0.59) HTR2CHTR2AHTR2BKDM1ATAAR1
SCHEMBL1643784 0.79 KDM1A (0.47) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL1643791 0.79 KDM1A (0.47) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL5004304 0.79 KDM1A (0.47) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL3841365 0.79 KDM1A (0.47) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL1643782 0.79 KDM1A (0.47) HTR2CHTR2AHTR2BKDM1AKDM1B
SCHEMBL15064669 0.77 HTR2C (0.45) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL807474 0.77 HTR2C (0.45) HTR2CHTR2AHTR2BKDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed